STERIS plc
NYSE:STE

Watchlist Manager
STERIS plc Logo
STERIS plc
NYSE:STE
Watchlist
Price: 214.34 USD -0.66% Market Closed
Market Cap: 21.2B USD
Have any thoughts about
STERIS plc?
Write Note

Wall Street
Price Targets

STE Price Targets Summary
STERIS plc

Wall Street analysts forecast STE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STE is 257.06 USD with a low forecast of 232.3 USD and a high forecast of 278.25 USD.

Lowest
Price Target
232.3 USD
8% Upside
Average
Price Target
257.06 USD
20% Upside
Highest
Price Target
278.25 USD
30% Upside

STE Last Price Targets
STERIS plc

The latest public price target was made on Oct 24, 2024 by Jason Bednar from Piper Sandler , who expects STE stock to rise by 21% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Jason Bednar
Piper Sandler
260 USD
Upside 21%
4 weeks ago
Oct 24, 2024
Piper Sandler Upgrades STERIS (STE) to Overweight
StreetInsider
Brett Fishbin
KeyBanc
265 USD
Upside 24%
2 months ago
Sep 3, 2024
Steris price target raised to $265 from $255 at KeyBanc
TheFly
Jason Bednar
Piper Sandler
225 USD
Upside 5%
6 months ago
May 10, 2024
STERIS (STE) PT Raised to $225 at Piper Sandler
StreetInsider
Mike Polark
Wolfe Research
245 USD
Upside 14%
7 months ago
Apr 4, 2024
STERIS (STE) PT Raised to $245 at Wolfe Research
StreetInsider
Jason Bednar
Piper Sandler
Price Target 260 USD
Upside/Downside 21%
View Source
Brett Fishbin
KeyBanc
Price Target 265 USD
Upside/Downside 24%
View Source
Jason Bednar
Piper Sandler
Price Target 225 USD
Upside/Downside 5%
View Source
Mike Polark
Wolfe Research
Price Target 245 USD
Upside/Downside 14%
View Source
STERIS plc Competitors:
Price Targets
SHL
Siemens Healthineers AG
21% Upside
EKF
EKF Diagnostics Holdings PLC
39% Upside
ITGR
Integer Holdings Corp
4% Upside
PDEX
Pro-Dex Inc
13% Upside
2235
MicroTech Medical Hangzhou Co Ltd
4% Upside
DIA
DiaSorin SpA
1% Downside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
38% Upside
SN
Smith & Nephew PLC
28% Upside

Revenue
Forecast

Revenue Estimate
STERIS plc

For the last 8 years the compound annual growth rate for STERIS plc's revenue is 11%. The projected CAGR for the next 3 years is 7%.

11%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
STERIS plc

For the last 8 years the compound annual growth rate for STERIS plc's operating income is 20%. The projected CAGR for the next 3 years is 18%.

20%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-44%
Average Miss

Net Income
Forecast

Net Income Estimate
STERIS plc

For the last 8 years the compound annual growth rate for STERIS plc's net income is 17%. The projected CAGR for the next 3 years is 42%.

17%
Past Growth
42%
Estimated Growth
Estimates Accuracy
-56%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is STE's stock price target?
Price Target
257.06 USD

According to Wall Street analysts, the average 1-year price target for STE is 257.06 USD with a low forecast of 232.3 USD and a high forecast of 278.25 USD.

What is STERIS plc's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for STERIS plc's revenue is 11%. The projected CAGR for the next 3 years is 7%.

What is STERIS plc's Operating Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for STERIS plc's operating income is 20%. The projected CAGR for the next 3 years is 18%.

What is STERIS plc's Net Income forecast?
Projected CAGR
42%

For the last 8 years the compound annual growth rate for STERIS plc's net income is 17%. The projected CAGR for the next 3 years is 42%.

Back to Top